COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,794 Articles (22,527 medRxiv, 8,267 bioRxiv)

Most recent first Previous |  Page 2660: Articles 26591-26600  | Next

Efficacy and Safety of Hydroxychloroquine and Chloroquine for COVID-19: A systematic review
Singh, S., Moore, T. J.
10.1101/2020.05.19.20106906 — Posted: 2020-05-26
Hydroxychloroquine alone or in combination with azithromycin to prevent major clinical events in hospitalised patients with coronavirus infection (COVID-19): rationale and design of a randomised, controlled clinical trial
Cavalcanti, A. B., Zampieri, F. G., Azevedo, L. C., Rosa, R. G., Avezum, A., Veiga, V. C., Lopes, R. D., Kawano-Dourado, L., Damiani, L. P., Pereira, A. J., Serpa Neto, A., Furtado, R., Tomazini, B., Bozza, F. A., Maia, I. S., Falavigna, M., Lisboa, T. C., Fonseca, H., Machado, F. R., Berwanger, O., COALITION COVID-19 Brazil I Investigators
10.1101/2020.05.19.20106997 — Posted: 2020-05-26
A Unique Clade of SARS-CoV-2 Viruses is Associated with Lower Viral Loads in Patient Upper Airways
Lorenzo-Redondo, R., Nam, H. H., Roberts, S. C., Simons, L. M., Jennings, L. J., Qi, C., Achenbach, C. J., Hauser, A. R., Ison, M. G., Hultquist, J. F., Ozer, E. A.
10.1101/2020.05.19.20107144 — Posted: 2020-05-26 Discussion: Onsite
Strict Physical Distancing May Be More Efficient: A Mathematical Argument for Making Lockdowns Count
Bilinski, A., Fitzpatrick, M. C., Sheffield, S. R., Swartwood, N. A., Williamson, A., York, A.
10.1101/2020.05.19.20107045 — Posted: 2020-05-26 Discussion: Onsite
ROBUST COVID-19-RELATED CONDITION CLASSIFICATION NETWORK
Lucius, M., Belvisi, M., Galmarini, C. M.
10.1101/2020.05.19.20106336 — Posted: 2020-05-26
Sample Pooling as a Strategy of SARS-COV-2 Nucleic Acid Screening Increases the False-negative Rate
Gan, Y., Du, L., Damola, F. O., Huang, J., Xiao, G., Lyu, X.
10.1101/2020.05.18.20106138 — Posted: 2020-05-26 Discussion: Onsite
European lockdowns and the consequences of relaxation during the COVID-19 pandemic
Glass, D. H.
10.1101/2020.05.19.20106542 — Posted: 2020-05-26
Eruption of COVID-19 like illness in a remote village in Papua (Indonesia)
van Burg, E., van Burg-Verhage, W.
10.1101/2020.05.19.20106740 — Posted: 2020-05-26
Hypertension and renin-angiotensin system blockers are not associated with expression of Angiotensin Converting Enzyme 2 (ACE2) in the kidney
Jiang, X., Eales, J. M., Scannali, D., Nazgiewicz, A., Prestes, P., Maier, M., Denniff, M. J., Xu, X., Saluja, S., Cano-Gamez, E., Wystrychowski, W., Szulinska, M., Antczak, A., Byars, S., Glyda, M., Krol, R., Zywiec, J., Zukowska-Szczechowska, E., Burrell, L. M., Woolf, A. S., Greenstein, A., Bogdanski, P., Keavney, B., Morris, A. P., Heagerty, A., Williams, B., Harrap, S. B., Trynka, G., Samani, N. J., Guzik, T. J., Charchar, F. J., Tomaszewski, M.
10.1101/2020.05.19.20106781 — Posted: 2020-05-26
Emergence of Low-density Inflammatory Neutrophils Correlates with Hypercoagulable State and Disease Severity in COVID-19 Patients
Morrissey, S. M., Geller, A. E., Hu, X., Tieri, D., Cooke, E. A., Ding, C., Woeste, M., Zhange, H.-g., Cavallazi, R., Clifford, S. P., Chen, J., Kong, M., Watson, C. T., Huang, J., Yan, J.
10.1101/2020.05.22.20106724 — Posted: 2020-05-26

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).